Clinical trials in the era of Covid-19: successes, failures & ongoing challenges

Published: 4 August 2020
Commentary
Sven Kili

In our July issue, Sven Kili focuses his regular analysis of current clinical trends on the far-reaching and in some cases devastating impact of the Covid-19 pandemic. From new investment trends and delayed trials to changes to approval processes, the shockwaves of the pandemic have been felt in almost every corner of the cell and gene therapy field.

Read now